Glomus Jugulare Tumors: How Endovascular and Surgical Teams Work Together

Glomus Jugulare Tumors: How Endovascular and Surgical Teams Work Together

Glomus jugulare tumors—a rare category of paraganglioma—develop within the jugular foramen, a complex passage at the base of the skull. This narrow anatomical corridor serves as the exit site for the internal jugular vein and critical cranial nerves (CN IX, X, and XI) that regulate swallowing, vocal cord movement, shoulder elevation, and tongue motion. Because glomus jugulare tumors are among the most hypervascular lesions in the human body, removing them requires a synchronized effort between interventional endovascular specialists and skull base neurosurgeons.

Clinical Presentation and Diagnostic Evaluation

Because glomus jugulare tumors expand gradually within the temporal bone, early symptoms are often localized to the ear and throat before progressing to neurological deficits:

• Pulsatile Tinnitus: A persistent, rhythmic swooshing or thumping sound in the ear that synchronizes with the patient’s heartbeat, caused by turbulent blood flow within the tumor’s dense arterial network.
• Conductive Hearing Loss and Balance Issues: Resulting from tumor growth into the middle ear space and erosion of surrounding bony structures.
• Lower Cranial Nerve Palsies: Hoarseness, swallowing difficulties (dysphagia), loss of gag reflex, and weakness in the trapezius muscle as cranial nerves IX, X, and XI become compressed against the skull base.

High-resolution CT scans evaluate bony erosion of the jugular foramen, while contrast-enhanced MRI and catheter digital subtraction angiography (DSA) map the extensive arterial network feeding the mass.

The Two-Stage Multidisciplinary Treatment Plan

Attempting to resect a hypervascular glomus tumor without prior intervention carries a high risk of intraoperative hemorrhage and injury to surrounding cranial nerves. To maximize surgical safety, treatment is staged:

Stage 1: Preoperative Endovascular Embolization

24 to 48 hours before surgical resection, an endovascular specialist performs catheter-directed embolization. Navigating microcatheters through the carotid artery branches supplying the tumor (such as the ascending pharyngeal artery), the specialist releases liquid embolic agents or micro-particles directly into the tumor bed. This intentionally shuts down internal blood flow, shrinking the tumor mass and reducing blood loss.

Stage 2: Microsurgical Skull Base Resection

With the tumor devascularized, the neurosurgical team performs a specialized skull base approach (such as an infratemporal fossa or transjugular approach). Guided by high-power operating microscopes and continuous intraoperative neurophysiological monitoring (IONM), surgeons peel the devascularized tumor away from the internal carotid artery, jugular vein, and lower cranial nerves.

• Book Online: Visit igeaneuro.com to request a comprehensive diagnostic consultation with our neurosurgical team.
• Call Our Team Today: Speak directly with our dedicated patient care coordinators at (866) 467-1770.